Sort   by:  
 Page size 
UnknownClinical Outcomes and Response to Vericiguat According to Index Heart Failure Event: Insights From the VICTORIA Trial.
Not available
S-EPMC7666431 | biostudies-literature
UnknownCulture-modified bone marrow cells attenuate cardiac and renal injury in a chronic kidney disease rat model via a novel antifibrotic mechanism.
Not available
S-EPMC2832011 | biostudies-literature
UnknownChanges in public preferences for technologically enhanced surveillance following the COVID-19 pandemic: a discrete choice experiment.
Not available
S-EPMC7677347 | biostudies-literature
UnknownGeneral practitioners' perspectives regarding early developmental surveillance for autism within the australian primary healthcare setting: a qualitative study.
Not available
S-EPMC10416397 | biostudies-literature
UnknownIntrinsic host susceptibility among multiple species to intranasal SARS-CoV-2 identifies diverse virological, biodistribution and pathological outcomes.
Not available
S-EPMC9636276 | biostudies-literature
UnknownParental experience of an early developmental surveillance programme for autism within Australian general practice: a qualitative study.
Not available
S-EPMC9710335 | biostudies-literature
UnknownSirtuin 1 activation attenuates cardiac fibrosis in a rodent pressure overload model by modifying Smad2/3 transactivation.
Not available
S-EPMC6148332 | biostudies-literature
UnknownSeroepidemiologic effects of influenza A(H1N1)pdm09 in Australia, New Zealand, and Singapore.
Not available
S-EPMC3557971 | biostudies-literature
UnknownEfficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial.
Not available
S-EPMC8009612 | biostudies-literature
UnknownClinical outcome and biomarker assessments of a multi-centre phase II trial assessing niraparib with or without dostarlimab in recurrent endometrial carcinoma.
Not available
S-EPMC10017680 | biostudies-literature
Sort   by:  
 Page size